White Papers

xMAP® Technology by Luminex

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures and markets the innovative xMAP® Technology with applications throughout the life-sciences industry, and clinical diagnostics. Open-architecture xMAP Technology enables multiplexing of biological tests (bioassays) reducing time, labor, and costs over traditional methods. Systems using xMAP Technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer.